335 related articles for article (PubMed ID: 17105592)
1. Effects of iron overload in a rat nutritional model of non-alcoholic fatty liver disease.
Kirsch R; Sijtsema HP; Tlali M; Marais AD; Hall Pde L
Liver Int; 2006 Dec; 26(10):1258-67. PubMed ID: 17105592
[TBL] [Abstract][Full Text] [Related]
2. Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency.
Kirsch R; Clarkson V; Verdonk RC; Marais AD; Shephard EG; Ryffel B; de la M Hall P
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):174-82. PubMed ID: 16706830
[TBL] [Abstract][Full Text] [Related]
3. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
Koppe SW; Sahai A; Malladi P; Whitington PF; Green RM
J Hepatol; 2004 Oct; 41(4):592-8. PubMed ID: 15464239
[TBL] [Abstract][Full Text] [Related]
4. MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes.
Larter CZ; Yeh MM; Williams J; Bell-Anderson KS; Farrell GC
J Hepatol; 2008 Sep; 49(3):407-16. PubMed ID: 18534710
[TBL] [Abstract][Full Text] [Related]
5. The role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitis.
Yamazaki Y; Kakizaki S; Horiguchi N; Sohara N; Sato K; Takagi H; Mori M; Negishi M
Gut; 2007 Apr; 56(4):565-74. PubMed ID: 16950832
[TBL] [Abstract][Full Text] [Related]
6. Hepatic mitochondrial oxidative metabolism and lipid peroxidation in iron-loaded rats fed ethanol.
Tector AJ; Olynyk JK; Britton RS; Janney CG; O'Neill R; Bacon BR
J Lab Clin Med; 1995 Dec; 126(6):597-602. PubMed ID: 7490519
[TBL] [Abstract][Full Text] [Related]
7. Essential pathogenic and metabolic differences in steatosis induced by choline or methione-choline deficient diets in a rat model.
Veteläinen R; van Vliet A; van Gulik TM
J Gastroenterol Hepatol; 2007 Sep; 22(9):1526-33. PubMed ID: 17716355
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.
Sahai A; Malladi P; Melin-Aldana H; Green RM; Whitington PF
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G264-73. PubMed ID: 15044174
[TBL] [Abstract][Full Text] [Related]
9. Interstrain differences in susceptibility to non-alcoholic steatohepatitis.
Yamazaki Y; Kakizaki S; Takizawa D; Ichikawa T; Sato K; Takagi H; Mori M
J Gastroenterol Hepatol; 2008 Feb; 23(2):276-82. PubMed ID: 17868334
[TBL] [Abstract][Full Text] [Related]
10. Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies.
Kirsch R; Clarkson V; Shephard EG; Marais DA; Jaffer MA; Woodburne VE; Kirsch RE; Hall Pde L
J Gastroenterol Hepatol; 2003 Nov; 18(11):1272-82. PubMed ID: 14535984
[TBL] [Abstract][Full Text] [Related]
11. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
[TBL] [Abstract][Full Text] [Related]
12. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice.
McCuskey RS; Ito Y; Robertson GR; McCuskey MK; Perry M; Farrell GC
Hepatology; 2004 Aug; 40(2):386-93. PubMed ID: 15368443
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
Farrell GC; Larter CZ; Hou JY; Zhang RH; Yeh MM; Williams J; dela Pena A; Francisco R; Osvath SR; Brooling J; Teoh N; Sedger LM
J Gastroenterol Hepatol; 2009 Mar; 24(3):443-52. PubMed ID: 19226377
[TBL] [Abstract][Full Text] [Related]
14. Quantitative trait loci analysis of mice administered the methionine-choline deficient dietary model of experimental steatohepatitis.
Rangnekar AS; Lammert F; Igolnikov A; Green RM
Liver Int; 2006 Oct; 26(8):1000-5. PubMed ID: 16953841
[TBL] [Abstract][Full Text] [Related]
15. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
[TBL] [Abstract][Full Text] [Related]
17. Glycine alleviates liver injury induced by deficiency in methionine and or choline in rats.
Barakat HA; Hamza AH
Eur Rev Med Pharmacol Sci; 2012 Jun; 16(6):728-36. PubMed ID: 22913202
[TBL] [Abstract][Full Text] [Related]
18. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice.
Min AK; Kim MK; Kim HS; Seo HY; Lee KU; Kim JG; Park KG; Lee IK
Life Sci; 2012 Jan; 90(5-6):200-5. PubMed ID: 22154902
[TBL] [Abstract][Full Text] [Related]
19. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA
Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
[TBL] [Abstract][Full Text] [Related]
20. A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet.
Baumgardner JN; Shankar K; Hennings L; Badger TM; Ronis MJ
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G27-38. PubMed ID: 17947452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
